Lexeo Therapeutics, Inc. Quarterly Debt-to-equity in % for Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Lexeo Therapeutics, Inc. quarterly Debt-to-equity history and growth rate for Q2 2024.
  • Lexeo Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 38.9 %.
Debt-to-equity, Quarterly (%)
Period Value YoY Chg Change % Date
Q2 2024 38.9 Jun 30, 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.